1. Home
  2. SOTK vs ONCY Comparison

SOTK vs ONCY Comparison

Compare SOTK & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

SELL

Current Price

$6.29

Market Cap

72.1M

Sector

Technology

ML Signal

SELL

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.50

Market Cap

80.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOTK
ONCY
Founded
1975
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
80.5M
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
SOTK
ONCY
Price
$6.29
$0.50
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
★ $8.50
$4.16
AVG Volume (30 Days)
134.1K
★ 1.3M
Earning Date
10-14-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
★ 0.07
N/A
Revenue
★ $20,909,315.00
N/A
Revenue This Year
$2.59
N/A
Revenue Next Year
$23.41
N/A
P/E Ratio
$87.21
★ N/A
Revenue Growth
★ 1.97
N/A
52 Week Low
$3.40
$0.44
52 Week High
$7.48
$1.32

Technical Indicators

Market Signals
Indicator
SOTK
ONCY
Relative Strength Index (RSI) 53.94 29.93
Support Level $4.07 N/A
Resistance Level $7.48 $0.89
Average True Range (ATR) 0.68 0.06
MACD -0.02 -0.01
Stochastic Oscillator 47.89 24.48

Price Performance

Historical Comparison
SOTK
ONCY

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: